Lopinavir News and Research

RSS
Potential covalent SARS-CoV-2 spike protein inhibitors

Potential covalent SARS-CoV-2 spike protein inhibitors

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

Potential pancoronavirus fusion inhibitors that are effective against SARS-CoV-2 variants

Flavonoid-based inhibitors targeting SARS-CoV 3CL protease for the treatment of SARS-CoV-2 infection

Flavonoid-based inhibitors targeting SARS-CoV 3CL protease for the treatment of SARS-CoV-2 infection

Water-soluble vitamin E compounds directly inhibit SARS-CoV-2 replication and synergize with remdesivir

Water-soluble vitamin E compounds directly inhibit SARS-CoV-2 replication and synergize with remdesivir

Anti-malarial drug shows promise in the battle against COVID-19

Anti-malarial drug shows promise in the battle against COVID-19

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Cyperus rotundus medicinal plant shows promise for novel COVID-19 therapeutics

Are COVID-19 medications safe in pregnancy?

Are COVID-19 medications safe in pregnancy?

Facets of SARS-CoV-2 infection and animal models

Facets of SARS-CoV-2 infection and animal models

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

ANTICOV clinical trial to test new treatment for people with mild-to-moderate COVID-19 in Africa

COVID-19 pandemic and nanotechnology

COVID-19 pandemic and nanotechnology

Could Ivermectin be an effective antiviral against SARS-CoV-2?

Could Ivermectin be an effective antiviral against SARS-CoV-2?

Disulfide-reducing agents demonstrate potential antiviral activity against SARS-CoV-2

Disulfide-reducing agents demonstrate potential antiviral activity against SARS-CoV-2

Researchers identify natural products with potential to disrupt viral spread

Researchers identify natural products with potential to disrupt viral spread

Azithromycin trial fails to provide evidence of benefit in COVID-19

Azithromycin trial fails to provide evidence of benefit in COVID-19

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

Copper gluconate supplementation could reduce SARS-CoV-2 infection in vitro

Favipiravir does not attenuate the progression of COVID-19

Favipiravir does not attenuate the progression of COVID-19

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Researchers use AI platform to identify best combination of available therapies against COVID-19.

Using AI to find optimal combination of available therapies against SARS-CoV-2

Using AI to find optimal combination of available therapies against SARS-CoV-2

New insight into role of autophagy in controlling SARS-CoV-2 infection

New insight into role of autophagy in controlling SARS-CoV-2 infection

Chinese woman still sheds SARS-CoV-2 over four months post-infection

Chinese woman still sheds SARS-CoV-2 over four months post-infection